Insider Trading Arrangements |
3 Months Ended |
|---|---|
|
Jun. 30, 2026
shares
| |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | Security Trading Plans of Directors and Executive Officers On June 16, 2026, Scott Greenwell, Executive Vice President and President, PharMerica, entered into a stock trading plan designed to comply with Rule 10b5-1 under the Exchange Act (the “Rule 10b5-1 Plan”). The Rule 10b5-1 Plan provides for the sale, subject to certain price limits, of up to 11,973 shares of the Company’s common stock. The Rule 10b5-1 Plan has a trading effective date of September 14, 2026, and no sales are permitted to occur before this date. The Rule 10b5-1 Plan will terminate on September 14, 2026, unless terminated earlier pursuant to the terms of the Rule 10b5-1 Plan. If all shares are pursuant to the Rule 10b5-1 Plan, Mr. Greenwell will continue to satisfy the Company’s stock ownership guidelines. |
| Scott Greenwell [Member] | |
| Trading Arrangements, by Individual | |
| Name | Scott Greenwell |
| Title | Executive Vice President and President |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | June 16, 2026 |
| Rule 10b5-1 Arrangement Terminated | true |
| Termination Date | September 14, 2026 |
| Expiration Date | September 14, 2026 |
| Arrangement Duration | 91 days |
| Aggregate Available | 11,973 |